Connecting the dots...Provectus Biopharmaceuticals
March 1, 2013
What a $PVCT #Week, #Month and #Year Thus Far
What year-to-date performance for PVCT, and versus the iShares Nasdaq Biotechnology Index (to compare): +43% v. +9% (+6.5% for the S&P 500 Index).
One year. Different: -8% v. +25% (+11.2%)
No comments:
Post a Comment
Newer Post
Older Post
Home
No comments:
Post a Comment